Methamphetamine abuse and emergency department utilization - PubMed (original) (raw)

. 1999 Apr;170(4):198-202.

Affiliations

• PMID: 10344172
• PMCID: PMC1305548

Methamphetamine abuse and emergency department utilization

J R Richards et al. West J Med. 1999 Apr.

Abstract

Methamphetamine (MAP) abuse continues to increase worldwide, based on morbidity, mortality, drug treatment, and epidemiologic studies and surveys. MAP abuse has become a significant health care, environmental, and law enforcement problem. Acute intoxication often results in agitation, violence, and death. Chronic use may lead to infection, heart failure, malnutrition, and permanent psychiatric illness. MAP users frequently use the emergency department (ED) for their medical care. Over a 6-month period we studied the demographics, type, and frequency of medical and traumatic problems in 461 MAP patients presenting to our ED, which serves an area noted for high levels of MAP production and consumption. Comparison was made to the general ED population to assess use patterns. MAP patients were most commonly Caucasian males who lacked health insurance. Compared to other ED patients during this time, MAP patients used ambulance transport more and were more likely to be admitted to the hospital. There was a significant association between trauma and MAP use in this patient population. Our data suggest MAP users utilize prehospital and hospital resources at levels higher than the average ED population. Based on current trends, we can expect more ED visits by MAP users in the future.

PubMed Disclaimer

Comment in

• The problem of methamphetamine toxicity.
  Karch S. Karch S. West J Med. 1999 Apr;170(4):232. West J Med. 1999. PMID: 10344179 Free PMC article. No abstract available.

Similar articles

• Methamphetamine-related emergency department utilization and cost.
  Hendrickson RG, Cloutier R, McConnell KJ. Hendrickson RG, et al. Acad Emerg Med. 2008 Jan;15(1):23-31. doi: 10.1111/j.1553-2712.2007.00006.x. Acad Emerg Med. 2008. PMID: 18211309
• Is the self-report of recent cocaine or methamphetamine use reliable in illicit stimulant drug users who present to the Emergency Department with chest pain?
  Lee MO, Vivier PM, Diercks DB. Lee MO, et al. J Emerg Med. 2009 Aug;37(2):237-41. doi: 10.1016/j.jemermed.2008.05.024. Epub 2008 Dec 11. J Emerg Med. 2009. PMID: 19081702
• Analysis of costs, length of stay, and utilization of emergency department services by frequent users: implications for health policy.
  Ruger JP, Richter CJ, Spitznagel EL, Lewis LM. Ruger JP, et al. Acad Emerg Med. 2004 Dec;11(12):1311-7. doi: 10.1197/j.aem.2004.07.008. Acad Emerg Med. 2004. PMID: 15576522
• The epidemiology of methamphetamine use and harm in Australia.
  Degenhardt L, Roxburgh A, Black E, Bruno R, Campbell G, Kinner S, Fetherston J. Degenhardt L, et al. Drug Alcohol Rev. 2008 May;27(3):243-52. doi: 10.1080/09595230801950572. Drug Alcohol Rev. 2008. PMID: 18368605 Review.
• The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992-2007.
  Maxwell JC, Rutkowski BA. Maxwell JC, et al. Drug Alcohol Rev. 2008 May;27(3):229-35. doi: 10.1080/09595230801919460. Drug Alcohol Rev. 2008. PMID: 18368603 Review.

Cited by

• Sex differences in (+)-amphetamine- and (+)-methamphetamine-induced behavioral response in male and female Sprague-Dawley rats.
  Milesi-Hallé A, McMillan DE, Laurenzana EM, Byrnes-Blake KA, Owens SM. Milesi-Hallé A, et al. Pharmacol Biochem Behav. 2007 Jan;86(1):140-9. doi: 10.1016/j.pbb.2006.12.018. Epub 2007 Jan 9. Pharmacol Biochem Behav. 2007. PMID: 17275894 Free PMC article.
• Molecular, Behavioral, and Physiological Consequences of Methamphetamine Neurotoxicity: Implications for Treatment.
  Moszczynska A, Callan SP. Moszczynska A, et al. J Pharmacol Exp Ther. 2017 Sep;362(3):474-488. doi: 10.1124/jpet.116.238501. Epub 2017 Jun 19. J Pharmacol Exp Ther. 2017. PMID: 28630283 Free PMC article. Review.
• At the borders, on the edge: use of injected methamphetamine in Tijuana and Ciudad Juarez, Mexico.
  Case P, Ramos R, Brouwer KC, Firestone-Cruz M, Pollini RA, Fraga MA, Patterson TL, Strathdee SA. Case P, et al. J Immigr Minor Health. 2008 Feb;10(1):23-33. doi: 10.1007/s10903-007-9051-0. J Immigr Minor Health. 2008. PMID: 17516170 Free PMC article.
• Reduced carboxylesterase 1 is associated with endothelial injury in methamphetamine-induced pulmonary arterial hypertension.
  Orcholski ME, Khurshudyan A, Shamskhou EA, Yuan K, Chen IY, Kodani SD, Morisseau C, Hammock BD, Hong EM, Alexandrova L, Alastalo TP, Berry G, Zamanian RT, de Jesus Perez VA. Orcholski ME, et al. Am J Physiol Lung Cell Mol Physiol. 2017 Aug 1;313(2):L252-L266. doi: 10.1152/ajplung.00453.2016. Epub 2017 May 4. Am J Physiol Lung Cell Mol Physiol. 2017. PMID: 28473326 Free PMC article.
• The need for speed: an update on methamphetamine addiction.
  Barr AM, Panenka WJ, MacEwan GW, Thornton AE, Lang DJ, Honer WG, Lecomte T. Barr AM, et al. J Psychiatry Neurosci. 2006 Sep;31(5):301-13. J Psychiatry Neurosci. 2006. PMID: 16951733 Free PMC article. Review.

References

1. 1. J Forensic Sci. 1989 Mar;34(2):407-22 - PubMed
2. 1. Forensic Sci Int. 1997 Feb 28;85(2):149-57 - PubMed
3. 1. J Emerg Med. 1989 Mar-Apr;7(2):157-61 - PubMed
4. 1. Ann N Y Acad Sci. 1992 Jun 28;654:160-70 - PubMed
5. 1. J Forensic Sci. 1993 Nov;38(6):1342-53 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information